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Abstract
Background: Currently, data about age-phenotype associations are not systematically organized and cannot be
studied methodically. Searching for scientific articles describing phenotypic changes reported as occurring at a
given age is not possible for most ages.
Results: Here we present the Age-Phenome Knowledge-base (APK), in which knowledge about age-related
phenotypic patterns and events can be modeled and stored for retrieval. The APK contains evidence connecting
specific ages or age groups with phenotypes, such as disease and clinical traits. Using a simple text mining tool
developed for this purpose, we extracted instances of age-phenotype associations from journal abstracts related to
non-insulin-dependent Diabetes Mellitus. In addition, links between age and phenotype were extracted from
clinical data obtained from the NHANES III survey. The knowledge stored in the APK is made available for the
relevant research community in the form of ‘Age-Cards’, each card holds the collection of all the information
stored in the APK about a particular age. These Age-Cards are presented in a wiki, allowing community review,
amendment and contribution of additional information. In addition to the wiki interaction, complex searches can
also be conducted which require the user to have some knowledge of database query construction.
Conclusions: The combination of a knowledge model based repository with community participation in the
evolution and refinement of the knowledge-base makes the APK a useful and valuable environment for collecting
and curating existing knowledge of the connections between age and phenotypes.
Background
The relationship between age and human health has been
extensively investigated over the years and age has been
linked to a plethora of so-called age-related diseases [1].
Ap a t i e n t ’sa g em a ye f f e c tt h ec o u r s ea n dp r o g r e s s i o no f
ad i s e a s e[ 2 , 3 ]o rm a yb ea ni m p o r t a n tf a c t o ri nd e t e r -
mining the right course of treatment [4]. As a result of
these endeavors, a significant quantity of data exists link-
ing specific ages or age ranges with disease, as well as
with other clinical phenotypes such as ‘normal’ parameter
values from blood tests.
Currently, data relating to age-phenotype associations
are not systematically organized and cannot be studied
methodically. For example, searching for scientific articles
describing the phenotypic changes reported to occur at a
given age is not possible for most ages. Consider for exam-
ple, the search for data on the change in serum hemoglo-
b i nl e v e l si np o s t - p a r t u mw o m e na g e d3 0 .I ti sf a i r l y
straightforward to discover works that discuss postpartum
hemoglobin level but simply searching for works associat-
ing hemoglobin with the term ‘age 30’ yields a huge
volume of work that mentions either the age of the indivi-
dual or the average age in the cases that were studied. It is
then necessary to find, by reading through the papers or
abstracts, that subset of these works that discuss some
events or trends relating to a particular age. For age-
related phenotypic changes to be useful for medical
research, not only are interactive searches much needed,
but the information retrieved should be amenable to com-
putational analysis. One approach to achieving these goals
is by means of a knowledge-base in which age-related
events, trends and phenotypic changes are recorded in a
structured knowledge representation model. With such a
knowledge-base, it should be possible to support dynamic
queries about events known to occur at specific ages or
within age ranges. Moreover, such a knowledge-base will
allow mining of existing knowledge for novel insights into
age-related processes.
Over the years, many efforts have been made to repre-
sent biomedical knowledge and make it accessible for
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to the emergence of many bio-medical knowledge-bases
[5]. However, most of the knowledge-bases that are con-
cerned with human phenotypes do not represent the
connection of these phenotypes to age. One such knowl-
edge-base is the Human Phenotype Ontology (HPO) [6],
which provides a standardized vocabulary of phenotypic
abnormalities encountered in human disease. The HPO
includes a set of terms which allow the description of
some age-related information such as age of onset (for
example, the term ‘Onset in early adulthood’)b u t
detailed knowledge linking age to phenotype is not
included. Online Mendelian Inheritance in Man
(OMIM) [7], another major phenotype-related knowl-
edge-base, maintains knowledge about age and the links
to disease, yet this knowledge is not structured and
includes only a limited range of phenotypes, such as
genetic disorders.
We present here the Age-Phenome Knowledge-base
(APK), in which knowledge about age-related phenotypic
patterns and events is modeled and stored. The knowl-
edge-base holds a structured representation of knowl-
edge, derived from the literature, about clinically-relevant
traits and trends which occur at different ages such as
disease symptoms and disease propensity. In addition,
the database underpinning the knowledge-base can hold
information about trends and trend changes in biomarker
values and anthropomorphic properties. Disease and age
are described using ontologies, allowing abstraction in
searches (for example, searching for evidence linking
“infectious diseases” and “children” instead of searching
for a specified list of diseases and a range of ages as
would be required for a relational database search). The
knowledge-base is populated, using computational text-
mining tools and human curation, with age-related
knowledge as found in the medical and scientific litera-
ture. In addition, the knowledge-base contains patterns
extracted from raw clinical data. Earlier analysis of such
patterns, using data sources such as the National Health
and Environmental Nutrition Survey and the Soroka
Maternity Database showed that non-trivial age trends
can be extracted from raw clinical data [8,9]. By combin-
ing these patterns with the age-related knowledge to be
found in the research corpus, it should be possible to
suggest new ways to consider patient age in the improve-
ment of patient care and to propose new research
avenues.
Results
Overall Structure of the APK
The Age-Phenome Knowledge-base contains evidence
connecting specific ages or age groups to phenotypes,
such as clinical traits. It comprises a relational database,
ontologies and a wiki used for knowledge representation
to the user community. The database stores all the evi-
dence instances and the ages and phenotypes to which
they are linked. Age and diseases are described using
the Age Ontology and the Human Disease Ontology
respectively. The Age Ontology is a very simple ontol-
ogy, developed specifically for this research, that allows
ages to be represented by grouping them into classes
similar to those defined in the Medical Subject Headings
(MeSH) controlled vocabulary [10]. In the Age Ontol-
ogy, age is defined as the time which has passed since
birth and is an attribute of a person (Figure 1). Minor
changes were introduced to the MeSH age definitions in
order to improve their formal logic consistency. For
example, in MeSH the term ‘Child’ is defined as ‘Ap e r -
son 6-12 years of age’ while the term ‘Preschool child’ is
defined as ‘A person 2-5 years of age’.T om a k et h e
class ‘Preschool child’ logically a sub-class of ‘Child’ in
the Age Ontology, the definition of ‘Child’ had to be
changed to ‘A person 2-12 years of age’. Though the
Age Ontology currently is small and has a very simple
design, its hierarchal structure is serving the intended
uses of the APK. In order to achieve a richer description
of ages this ontology will be further developed in the
future.
The second ontology in use for the APK is the Human
Disease Ontology (DO) [11] which organizes and
describes diseases and was designed for use in clinical
research and in Medicine. DO was incorporated into the
APK to represent diseases as one form of phenotype. An
additional resource, a collection of clinical traits not
found in DO but occurring in the APK source docu-
ments, allows the scope of the APK to be extended to
cover other clinical age-related processes, such as
changes in common clinical markers. This collection may
be improved by adding higher-order terms that abstract
its terms, giving a meaningful structure to the collection
in the context of the APK. This kind of abstraction could
be supported by importing relevant terms from the
SNOMED-CT clinical terminology [12]. However, since
this ontology requires licensing, its incorporation into the
APK will be considered for a future enhancement of the
APK.
Each evidential text fragment stored in the knowledge-
base is linked to the specific age (or age range) and pheno-
type(s) mentioned by it. Five different types of relation-
ships were used to describe the links between evidence
and age. These five types describe the most commonly
occurring age-phenotype relationship contexts: ‘Age of
Onset’, ‘Age of Diagnosis’, ‘Age of Observation’, ‘Age of
Occurrence’ and ‘Age of Evaluation’. ‘Age of Onset’ is used
to link age to evidence describing the age of the beginning
of manifestation of the phenotype. ‘Age of Diagnosis’
is used when the evidence describes the age at which a
phenotype (usually a disease) is first diagnosed. ‘Age of
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at a specific age, for example a change in the phenotype
‘hemoglobin level’. ‘Age of Evaluation’ is used when the
evidence describes an evaluation of a phenotype in a cer-
tain age or age range, only indirectly asserting that these
ages may have been selected to evaluate the phenotype for
ar e a s o n .‘Age of Occurrence’ is used to link age to evi-
dence when the evidence describes a non-dependent
occurrence of phenotype at a certain age but without
asserting that the age has a direct effect on the phenotype.
To demonstrate the approach used here for capturing
and making medical knowledge linking age to disease avail-
able, the APK was populated with concrete examples.
Using a simple text mining tool developed for this purpose,
139 instances of age-phenotype associations were extracted
from 100 abstracts related to non-insulin-dependent Dia-
betes Mellitus. A further 239 examples of links between
age and phenotype were extracted from clinical data
obtained from the NHANES III survey. The knowledge-
base was then populated with the resulting 378 evidence
instances, together with their mapping to the correspond-
ing age and phenotype. A summary of the data stored in
the APK is provided in Figure 2. During the manual popu-
lation of the knowledge-base, it was noticed that it is some-
times challenging even for a human reader to select the
relationship type that best describes the type of age referred
to in the text segments. For example, in the text “Serum
and lipoprotein lipids were examined in 133 newly diag-
nosed (type II) diabetic patients (70 men, 63 women), aged
45-64 yr, and in 144 randomly selected non-diabetic control
subjects of similar age (62 men, 82 women). The serum total
cholesterol levels in diabetic and non-diabetic subjects were
similar, but the HDL-cholesterol levels were lower and the
serum total triglyceride levels higher in the diabetic than in
non-diabetic subjects“ there are two statements made
regarding the age range 45-64 years. The first is that the
patients investigated were 45-64 years old when diagnosed
with Diabetes, and the second is that this age range was
used when evaluating cholesterol and triglyceride levels in
diabetic patients. In order to capture the age-related
knowledge in this text, two evidence instances were
created. The first (APKID_138) linking Diabetes to the
ages 45-64 with the ‘Age of Diagnosis’ relationship; and the
second (APKID_101) linking these ages to ‘Diabetes’,
‘serum total cholesterol’, ‘HDL-cholesterol levels’,a n d
‘serum total triglyceride levels’ with the ‘Age Of Evaluation’
relationship. Automatically resolving this kind of relation-
ship assignment would require sophisticated natural lan-
guage processing tools and it seems unlikely that a fully
automatic system could be developed in the near future. It
was therefore decided to harness the “wisdom of the
crowd” by engaging user communities in identifying and
correcting erroneous machine interpretations of text. This
approach is manifested in the development of “age cards”
that were made available to interested readers as pages in a
wiki. The wiki technology was successful in engaging a
community of relevant readers in amending and extending
the knowledge items, with Wikipedia as the shining exam-
ple [13]. As in Wikipedia, readers of the age-phenome Age
Cards can add comments, propose new entries and correct
Figure 1 Age-range classes defined by the Age Ontology. Age-range classes were generally defined based on the MeSH age range
definitions, with minor changes introduced to improve consistency. In the Age Ontology, age-range classes that are contained within another
age-range class are defined as subclasses of that class. Each age-range class is made disjoint from all other age-range classes since each specific
age can belong to only one age range class. * This age range was modified from the MeSH definition.
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the community edits are collected from the history section
of the Wiki, and incorporated into the knowledge-base fol-
lowing manual curation.
Many scientific texts refer to age ranges, such as 2-7
years, rather than one specific age. In such cases, the evi-
dence instance is linked to the age range defined in the
database by the minimum and the maximum values of the
range. In some cases, the age range is not fully con-
strained, for example “30 years or less” and there are two
possible approaches to resolving this issue. The evidence
instance could be linked only to the age specifically men-
tioned, that is, 30 years in this example. In this case, some
information will most likely be missed. The second option,
and the one employed in the APK, is to link the evidence
instance to all the possible ages covered by the expression,
producing links to 0-30 for “30 years or less”. Although
this approach might add erroneous links, since the author
might not have intended all ages under 30 years, no infor-
mation will be missed. In future development of the APK,
more sophisticated natural language processing will be
used to attempt to locate and extract a more precise age
range from the full article since this is likely to appear in
the methods or results sections. For example, in a text dis-
cussing “children”, these sections may contain the exact
range such as 3-6 years of age.
Using the APK
One way to use the APK is to extract all the information
linked via evidence instances to a specific age or age-
range. This can answer questions such as “what type of
studies involve 30 year old individuals?” In the example
shown in Figure 3A, the age ‘30 years’ was queried and the
phenotypes linked to this age via the ‘Age of Evaluation’
relationship are shown.
Another way to use the APK is to locate all the speci-
fic ages and the age-ranges in the Age Ontology that are
linked (via evidence instances) to a specific phenotype of
interest or to a combination of phenotypes. In the
e x a m p l es h o w ni nF i g u r e3 B ,a l lt h ea g e sl i n k e dt o
‘Non-insulin-dependent Diabetes Mellitus’ AND ‘Hyper-
tension’ were extracted, with the results being filtered by
their year of publication. From the query results, it may
be seen that in the APK there are three evidence
instances in which these two diseases (phenotypes) were
evaluated and that the age-ranges used for the evalua-
tions partially overlap.
It must be stressed that the examples provided here are
somewhat simplistic. More complex queries can use, for
example, the Age Ontology and the Disease Ontology’s
hierarchal structures. It is possible, for example, to search
for evidence linking childhood infectious diseases and
Diabetes, using the Age Ontology to translate “child-
hood” into an age range and to enumerate those diseases
in the APK that are associated with the “infectious dis-
eases” class in the DO. Thus, as the APK becomes more
extensively populated with evidential instances, queries
can become more complex and their results are expected
to become more interesting and informative.
It should be noted that, in the current implementa-
tion, conducting complex queries in the APK requires
some familiarity with the SQL language.
The Age-Phenome Wiki
The Age-Phenome Wiki was developed as a means to
share the knowledge stored in the APK and to harness the
knowledge and expertise of the user community in further
developing the APK. This Wiki is constructed of ‘Age
Cards’ which are generated in a semi-automatic fashion.
For each specific age there is an Age-Card which contains
all information linked to that age to be found in the APK.
Each Age-Card has two versions. The first version is for
viewing the information and uses highlighted text and col-
ors for clearer presentation. The second version is created
for community edits, avoiding formatting instructions
(such as coloring) making it easy for untrained users to
Figure 2 The Age-Phenome database’sc o n t e n t ss u m m a r y . A. Instances per relationship type. Only instances extracted from PubMed
abstracts are shown. B. Instances per Age Ontology age class. An instance is assigned the most specific Age Ontology class which contains the
whole of the age range that that instance linked to. C. The top diseases from DO linked to instances in APK.
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into the database, allowing the knowledge-base to grow
and become more accurate based on readers’ input. Cur-
rently, this integration is carried out manually by curators
who review the revision history of the cards. However, as
the volume of editing increases, the tools that are currently
used to read and parse the literature will be used to parse
the edits, reducing the manual review and editing load.
Discussion
There is a wide consensus that age is an important fac-
tor when considering phenotypic changes in health and
disease. Though relationships and dependencies between
age and phenotype can be extracted from clinical data
and are widely discussed in medical literature, there is
at present no system which allows methodical investiga-
tion of the biological meaning of such relationships.
Even the task of assembling all the information about a
specific age is labor intensive, requiring the review of
massive bodies of literature, and may only yield a small
number of relevant works.
The Age-Phenome Knowledge-base is being developed
in order to create a knowledge representation of multiple
types of links between age and phenotypes. These links
are supported by various forms of evidence, such as
excerpts from scientific publications and results of clinical
Figure 3 Querying the APK. A. the APK was queried for phenotypes linked to age 30 years. The results show 4 (of 19) evidence instances that
were found linked to this age via the ‘Age Of Evaluation’ relationship and the different phenotypes linked to these evidence instances. B. the
APK was queried for ages linked to the phenotypes ‘Non-insulin-dependent Diabetes Mellitus’ and ‘Hypertension’. The query was restricted for
evidence instances with a publication year after 1990 and the age-range classes to which the resulting ages belong to were also extracted from
the Age Ontology. The results of this query show three evidence instances linked to both phenotypes, their publication year, the ages each
evidence instance is linked to and the age-range classes they belong to.
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with both evidence instances and with relationships which
connect age to phenotype via the evidence instances, it
can be used to answer questions regarding different ages
and how they might affect phenotype (and vice versa). Sev-
eral potential uses may be envisaged for the APK, the most
straightforward of these being to present age-phenotype
interrelationships in a readable and searchable form. To
reach its critical mass of current knowledge, it seems very
likely that the development of the APK will require a com-
munity effort, much like other knowledge-bases [14]. To
facilitate this effort, a wiki-structured representation of the
knowledge-base has been implemented. Through this wiki,
users are able to review and amend the information stored
in the knowledge-base, flagging erroneous interpretation
of the text or suggesting alternative or contradictory evi-
dence. For example, if an outdated abstract connects a dis-
ease to a specific age and this connection has since been
disproved then the user can edit the entry, suggesting the
correction to the curators. To facilitate the inclusion of
user-added knowledge whilst protecting the integrity of
the knowledge-base, user suggestions are processed
(manually or automatically) prior to their transfer back
into the knowledge-base.
The principal use of the knowledge-base is to answer
questions regarding linkages between age and phenotype.
An example of this kind of use is the observation made in
our lab, that post-partum hemoglobin peaks at the age of
30. This raises the question of what other phenotypic
changes occur at that age. With the APK, it is possible to
query the knowledge-base and find which phenotypes are
linked to this precise age (30), or approximate ages (29-31,
for example) or the same age group (adults). The query
results can be filtered by types of evidence which link the
age and phenotype and by parameters such as publication
dates of text evidence. Also, since phenotypes are defined
with an ontological structure, the query could be restricted
to phenotypes that pertain to a specific physiological sys-
tem. The APK could also be used to assist users in experi-
mental design by identifying the optimal age or age group
for investigating a specific phenotype.
The use of formal ontologies for representation of phe-
notypes and age allows queries at any level of abstraction-
generalization that interests the user. Phenotypes linked to
a certain age can be viewed at different resolutions (high
level or detailed) and ages linked to a specific phenotype
can be viewed both as specific ages such as 30 years old or
more general age-range classes, like adult. This approach
can be further extended to consider unsupervised searches
for patterns. Given a well populated database, it should be
possible to generate promising hypotheses by detecting
linkages between phenotypes and recurrent critical ages.
Another use of the knowledge-base is to redefine
meaningful age groups. Currently, age groups in the Age
Ontology are fashioned aftert h ed e f i n i t i o n su s e di n
MeSH [10] and seem to be rather simplistic. Once the
knowledge-base is more extensively populated with evi-
dence instances, it should be possible to re-evaluate
these classifications of ages. For example, if many evi-
dence instances indicate some age-ranges that are not
currently defined as a group, this may indicate that the
age-range is important with respect to a specific aspect
of Medicine or Biology and should be added to the Age
Ontology.
Future development of the APK
The APK is currently at an early stage of development
and further work is needed for the knowledge-base and
wiki to reach their full potential. One of the goals of
this paper is to engage potential users in contributing to
the APK, either by editing the relevant wiki entries or
by directing attention (also through the wiki) to specific
areas in which age-related knowledge is likely to be
helpful. Evaluation of user feedback will also allow the
improvement of the Age-Phenome Wiki.
Presently, adding knowledge to the APK requires
manual editing by domain experts. In order for the APK
to become widely used, it must be extended to include
far more complete descriptions of existing knowledge. It
is worth noting here that most of the applications of the
APK involve inspection of the results by domain experts.
As a result, a process that adds knowledge automatically
to the APK, even with only moderate accuracy, could
still be very useful. Consequently, tools are now being
developed that will be able to extract relevant knowl-
edge linking ages to phenotypes from the millions of
processed PubMed abstracts. A more robust knowledge
extraction pipeline is being developed that will mine
abstracts listed in PubMed for relevance to any age, and
find any of the predefined relationships to phenotype,
such as different diseases. For this next stage, existing
information extraction techniques and programs [15,16]
will be used with their possible adaptation to this speci-
fic use.
F r o mt h ee x p e r i e n c eg a i n e di nt h i sw o r k ,i th a s
become evident that it is necessary to analyze the full
text of the relevant literature; some abstracts are
ambiguous and some lack critical information. It is
therefore planned to mine Pub Med Central [17] to
seek age-phenotype relationships in whole papers. In
the future, collaborations with relevant publishers and
content providers may allow even more complete cov-
erage of the literature. Advancing to analysis of the full
text of the relevant papers will require more powerful
text mining techniques, and will involve specific
adjustment of the pipeline for complete text analysis,
for example treating the methods and the results sec-
tions differently.
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The design, development and preliminary testing of a
knowledge-base of age-related phenotypic changes in
humans are described. At the current level of knowledge
represented in the APK, it is limited to being a demon-
stration of the concept and its potential uses. Neverthe-
less, the Age-Phenome wiki may engage the research
community and bring about rapid population of the
knowledge-base with knowledge from specific domains
such as Diabetes. The APK will immediately make this
knowledge searchable in ways which are not currently
achievable in other knowledge sources. The combination
of a structured knowledge model along with community
participation in its evolution, makes the APK a promis-
ing platform for collecting existing knowledge concern-
ing the interplay between age and phenotypes.
Methods
The Age-Phenome database
The database, written in MySQL [18], comprises four
main data tables (Figure 4):
(i) The evidence table contains all the pieces of evi-
dence and their description.
(ii) The evidence-age table contains a description of
the age information found in each evidence instance.
Figure 4 The Age-Phenome Database’s overall structure. The Age-Phenome database comprises of 4 main data-tables: (1) Evidence, (2)
Evidence-age, (3) Evidence-phenotype, and (4) Age-Phenotype relationships. In the Evidence table each evidence instance has a unique identifier
and is characterized by: ‘Evidence type’, ‘Evidence text’, ‘Analysis description’ (for evidence computationally derived from clinical data rather than
literature), ‘Title’, ‘Publication’, ‘Publication type’, ‘Publication year’, ‘MeSH terms’ (for evidence taken from literature), ‘ID in source’, ‘Source name’
and ‘Source URL’. The ‘Evidence text’ field holds an evidential text fragment. In the evidence-age table, each entry records the age or age range
that the evidence instance is linked to, using ‘range min’ and ‘range max’ fields to describe ranges as well as single ages (using identical range
min and max values). In the evidence-phenotype table, values for the ‘disease’ and ‘Additional phenotypes’ fields are taken from the Disease
Ontology, and a locally compiled additional phenotypes list (phenotypes such as different blood, available as Additional file 4), respectively. In
the age-phenotype-relationship table, each evidence instance is linked to one of five different relationships (’Age of Onset’, ‘Age of Diagnosis’,
‘Age of Occurrence’, ‘Age of Observation’ and ‘Age of Evaluation’).
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to each evidence instance.
(iv) The age-phenotype-relationship table is used to
record the type of relationship linking the age and
phenotype mentioned in each evidence instance.
Ontologies
The Age Ontology was developed and maintained using
the Protégé 4.0 Beta OWL editor [19], and was written
i nt h eO W L - D Ll a n g u a g e .T h eo n t o l o g yi sa v a i l a b l ea s
Additional file 1. The Human Disease Ontology (DO)
[11] was downloaded (December 2009) from the Open
Biomedical Ontologies Foundry [20] and imported into
the knowledge-base.
Information extraction
As a test case, PubMed [17] was searched for articles on
non-insulin dependent Diabetes Mellitus (Type 2 Dia-
betes). The search was restricted to human-related arti-
cles with all the ‘ages’ search options selected in the
‘Advanced’ search settings, as of November 2009. This
search yielded approximately 22,000 abstracts.
A script, implemented in Perl, used a list of regular
expressions (available as Additional file 2) to determine
which of the abstracts were related to age. One hundred
of the resulting abstracts were then manually searched
for the specific age being addressed, the type of connec-
tion to phenotype and the specific disease. From these
abstracts 139 instances for the knowledge-base were cre-
ated, each describing the link of a specific age (or age
range) to a disease or set of diseases. Basic age-related
information contained in these abstracts was captured
for each instance in the APK.
Clinical data
Data obtained from the NHANES III survey [21] was ana-
lyzed for age related trends. For a full description of the
analysis see the “A method for identifying critical ages
from clinical laboratory cross-sectional data” published at:
http://rubinlab.med.ad.bgu.ac.il/APK_clinical.html.
An evidence instance was generated for each observa-
tion made from the data analysis; 239 evidence instances
were added to the knowledge-base, together with their
connections to age and phenotype.
The Age-Phenome Wiki
The Age-Phenome Wiki was built using the MediaWiki
platform [22] and is available at: http://age-phenome-
wiki.med.ad.bgu.ac.il
Database availability
The APK database is available as a MySQL dump in
Additional file 3 and a list of additional phenotypes that
were mapped to evidence texts in APK can be found in
Additional file 4.
Additional material
Additional file 1: The Age Ontology. This file contains the Age
Ontology, developed in the OWL-DL language.
Additional file 2: Age relating terms. This file contains a list of regular
expressions that were used to determine which of the abstracts were
related to age.
Additional file 3: The APK database. This compressed folder contains
the APK database as a MySQL dump.
Additional file 4: List of additional phenotypes. This file contains a list
of additional phenotypes that were mapped to evidence texts in APK.
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